NEW YORK (Reuters Health) – Performing percutaneous coronary interventions (PCI) in non-infarct-related coronary vessels along with primary PCI for ST-segment elevation myocardial infarction (STEMI) appears to jeopardize patient…
NEW YORK (Reuters Health) – The optimal choice of transurethral procedure for benign prostatic hyperplasia is not made much easier by a new meta-analysis, published online June 11…
NEW YORK (Reuters Health) – In the treatment of nodular goiter, the effect of radioiodine (I-131) therapy is potentiated by neoadjuvant administration of recombinant human thyroid stimulating hormone…
NEW YORK (Reuters Health) – Propofol may be preferable to ketamine for procedural sedation in the emergency department, researchers conclude in a study published online June 2 in…
NEW YORK (Reuters Health) – For locally advanced and metastatic prostate cancer, the best timing and duration of androgen-deprivation therapy (ADT) is unclear. Now, a systematic review suggests…
NEW YORK (Reuters Health) – High-power laser vaporization is a safe and effective alternative to transurethral resection of the prostate (TURP) for benign prostatic hyperplasia, results of a…
NEW YORK (Reuters Health) – The extent to which doxycycline slows the progression of knee osteoarthritis (OA) is not the same in neutrally aligned (non-varus) and malaligned (varus,…
NEW YORK (Reuters Health) – For benign prostatic hyperplasia (BPH), monopolar transurethral resection of the prostate (TURP) is being increasingly challenged as the gold standard. Two randomized controlled…
NEW YORK (Reuters Health) – In selected patients with upper tract urothelial carcinoma, endoscopic management offers a nephron-sparing alternative to nephroureterectomy, researchers report in the June issue of…
NEW YORK (Reuters Health) – A quantitative immunochemical fecal occult blood test (FOBT) is superior to the standard guaiac-based FOBT for detecting advanced colorectal neoplasms and cancer, say…